Title : PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers.

Pub. Date : 2020 Jan 28

PMID : 31669203






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PARP1 inhibitor (Niraparib, Olaparib, Rucaparib) maintenance therapy improves progression-free survival in platinum sensitive sporadic epithelial ovarian cancers. Platinum poly(ADP-ribose) polymerase 1 Homo sapiens